Efficacy of trimethoprim-sulfamethoxazole for prophylaxis of Pneumocystis carinii pneumonia in patients with connective tissue disease.

被引：0
|
作者：
Okada, J [1 ]
Rana, M [1 ]
Kadoya, A [1 ]
Kondo, H [1 ]
机构：
[1] KITASATO UNIV,SCH MED,DEPT INTERNAL MED,KANAGAWA 228,JAPAN
来源：
ARTHRITIS AND RHEUMATISM | 1997年 / 40卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：462 / 462
页数：1
相关论文
共 50 条
  • [41] Once weekly trimethoprim-sulfamethoxazole for Pneumocystis jirovecii pneumonia prophylaxis in children with cancer
    McMullan, Brendan
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2014, 50 (06) : 491 - 491
  • [42] Comparative effectiveness of trimethoprim-sulfamethoxazole versus atovaquone for the prophylaxis of pneumocystis pneumonia in patients with connective tissue diseases receiving prolonged high-dose glucocorticoids
    Sadao Jinno
    Kengo Akashi
    Akira Onishi
    Yoko Nose
    Mai Yamashita
    Jun Saegusa
    Rheumatology International, 2022, 42 : 1403 - 1409
  • [43] Reduction of Pneumocystis jirovecii pneumonia and bloodstream infections by trimethoprim-sulfamethoxazole prophylaxis in patients with rheumatic diseases
    Honda, N.
    Tagashira, Y.
    Kawai, S.
    Kobayashi, T.
    Yamamoto, M.
    Shimada, K.
    Yokogawa, N.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2021, 50 (05) : 365 - 371
  • [44] 'Once weekly trimethoprim-sulfamethoxazole for Pneumocystis jirovecii pneumonia prophylaxis in children with cancer'
    McMullan, Brendan
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2014, 50 (05) : 415 - 415
  • [45] Safety and efficacy of prophylaxis for Pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantation
    G. V. Ramesh Prasad
    Jill Beckley
    Mohit Mathur
    Madhushankar Gunasekaran
    Michelle M. Nash
    Lindita Rapi
    Michael Huang
    Jeffrey S. Zaltzman
    BMC Infectious Diseases, 19
  • [46] Comparative effectiveness of trimethoprim-sulfamethoxazole versus atovaquone for the prophylaxis of pneumocystis pneumonia in patients with connective tissue diseases receiving prolonged high-dose glucocorticoids
    Jinno, Sadao
    Akashi, Kengo
    Onishi, Akira
    Nose, Yoko
    Yamashita, Mai
    Saegusa, Jun
    RHEUMATOLOGY INTERNATIONAL, 2022, 42 (08) : 1403 - 1409
  • [47] Safety and efficacy of prophylaxis for Pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantation
    Prasad, G. V. Ramesh
    Beckley, Jill
    Mathur, Mohit
    Gunasekaran, Madhushankar
    Nash, Michelle M.
    Rapi, Lindita
    Huang, Michael
    Zaltzman, Jeffrey S.
    BMC INFECTIOUS DISEASES, 2019, 19 (1)
  • [48] TRIMETHOPRIM SULFAMETHOXAZOLE CONCENTRATIONS IN PNEUMOCYSTIS-CARINII PNEUMONIA
    ERDMAN, SM
    RODVOLD, KA
    DICP-THE ANNALS OF PHARMACOTHERAPY, 1991, 25 (09): : 941 - 942
  • [49] TRIMETHOPRIM-SULFAMETHOXAZOLE APPEARS MORE EFFECTIVE THAN AEROSOLIZED PENTAMIDINE AS SECONDARY PROPHYLAXIS AGAINST PNEUMOCYSTIS-CARINII PNEUMONIA IN PATIENTS WITH AIDS
    CARR, A
    TINDALL, B
    PENNY, R
    COOPER, DA
    AIDS, 1992, 6 (02) : 165 - 171
  • [50] PNEUMOCYSTIS-CARINII PNEUMONITIS SUCCESSFULLY TREATED WITH TRIMETHOPRIM-SULFAMETHOXAZOLE
    MCLENNAN, G
    ANTIC, R
    SEYMOUR, AE
    FRITH, PA
    CLARKSON, AR
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1977, 7 (03): : 299 - 301
12345